News & Updates

GLP-1RAs lower depression risk in older adults with T2D

03 Mar 2025

The incidence of depression among older adults with type 2 diabetes is low, and the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) helps reduce the risk of depression relative to dipeptidyl peptidase-4 inhibitors (DPP4is), but not sodium–glucose cotransporter-2 inhibitors (SGLT2is).

GLP-1RAs lower depression risk in older adults with T2D

03 Mar 2025

Can semaglutide curb drinking?

02 Mar 2025 by

The glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide has the potential to reduce alcohol cravings and consumption in adults with alcohol use disorder (AUD), as shown in a phase II study.

Can semaglutide curb drinking?

02 Mar 2025

Machine learning model for predicting progression to schizophrenia feasible

28 Feb 2025

Analysis of routine clinical data via machine learning show promise for predicting the progression to schizophrenia within 5 years among patients with pre-existing mental illness, as shown in a study.

Machine learning model for predicting progression to schizophrenia feasible

28 Feb 2025

PCOS linked to unfavourable eating patterns among middle-aged women

25 Feb 2025

Women with polycystic ovarian syndrome (PCOS) in their middle years are prone to exhibiting unfavourable eating behaviours, according to a study.

PCOS linked to unfavourable eating patterns among middle-aged women

25 Feb 2025

Cognitive behavioural therapy: Online just as good as in-person delivery

21 Feb 2025

A retrospective cohort study has shown that short first-line treatments with therapist-guided, internet-delivered cognitive behavioural therapy (CBT) yield comparable outcomes as face-to-face CBT.

Cognitive behavioural therapy: Online just as good as in-person delivery

21 Feb 2025

Review pinpoints factors tied to teen depression in SG

20 Feb 2025 by

A systematic review of eight studies identified a range of factors associated with depression among adolescents in Singapore.

Review pinpoints factors tied to teen depression in SG

20 Feb 2025

Probiotics may be a promising treatment for depression

20 Feb 2025 by

Probiotics may be efficacious either as an adjunct to antidepressants or as a standalone treatment for major depressive disorder (MDD), according to results of a meta-analysis and network systematic review.

Probiotics may be a promising treatment for depression

20 Feb 2025

Risk of suicide high among people with headache disorders

17 Feb 2025

Headache disorders appear to be associated with an elevated risk of suicide, as reported in a population-based cohort study from Denmark.

Risk of suicide high among people with headache disorders

17 Feb 2025

Glutamatergic meds beneficial in obsessive-compulsive disorder

12 Feb 2025

Glutamatergic medications appear to be efficacious in the treatment of individuals with obsessive-compulsive disorder, according to the results of a meta-analysis.

Glutamatergic meds beneficial in obsessive-compulsive disorder

12 Feb 2025

Psilocybin shows promise for treatment-resistant depression

11 Feb 2025 by

The use of single-dose psilocybin offers potential safety and efficacy in patients with severe treatment-resistant depression (TRD), a study has shown.

Psilocybin shows promise for treatment-resistant depression

11 Feb 2025

News & Updates

Filter by Specialty:

Specialty:

GLP-1RAs lower depression risk in older adults with T2D

GLP-1RAs lower depression risk in older adults with T2D

Can semaglutide curb drinking?

Can semaglutide curb drinking?

Machine learning model for predicting progression to schizophrenia feasible

Machine learning model for predicting progression to schizophrenia feasible

PCOS linked to unfavourable eating patterns among middle-aged women

PCOS linked to unfavourable eating patterns among middle-aged women

Cognitive behavioural therapy: Online just as good as in-person delivery

Cognitive behavioural therapy: Online just as good as in-person delivery

Review pinpoints factors tied to teen depression in SG

Review pinpoints factors tied to teen depression in SG

Probiotics may be a promising treatment for depression

Probiotics may be a promising treatment for depression

Risk of suicide high among people with headache disorders

Risk of suicide high among people with headache disorders

Glutamatergic meds beneficial in obsessive-compulsive disorder

Glutamatergic meds beneficial in obsessive-compulsive disorder

Psilocybin shows promise for treatment-resistant depression

Psilocybin shows promise for treatment-resistant depression